Skip to main content

Table 1 Characteristics of the cohort ( n= 130)

From: Clinical predictors of successful magnetic resonance-guided focused ultrasound (MRgFUS) for uterine leiomyoma

Characteristic Mean ± SD
Patient  
 Age at treatment (years) 45.1 ± 5.5
 BMI (kg/m2) (n = 95)  
 <25 52 (54.7)
 25 to 29 26 (27.4)
 ≥30 17 (17.9)
 Race (n = 88)  
 Caucasian 77 (87.5)
 Other 11 (12.5)
 Smoking history (n = 123)  
 No 82 (66.6)
 Yes 41 (33.3)
 Gravidity (n = 129)  
 Nulligravid 59 (45.7)
 Multigravid 70 (54.3)
 Parity (n = 129)  
 Nulliparous 70 (54.3)
 Multiparous 59 (45.7)
 Menopausal status (n = 129)  
 Premenopausal 110 (92.4)
 Perimenopausal 8 (6.7)
 Postmenopausal 1 (0.8)
 Prior fibroid treatment  
 None 96 (73.8)
 Medical 22 (16.9)
 Myomectomy 2 (1.5)
 Endometrial ablation 2 (1.5)
 MRgFUS 8 (6.2)
Symptom  
 Age at first diagnosis (years) (n = 104) 41.5 ± 6.2
 Duration of dominant symptom (months) (n = 98) 20.6 ± 15.7
 Presenting symptoms (n = 124)  
 Bleeding + Bulk 39 (31.0)
 Bleeding only 32 (25.4)
 Bulk only 35 (27.8)
 Pain (±Bleeding or Bulk) 20 (15.9)
 Baseline symptom severity score (n = 66) 59.1 ± 18.0
Fibroid  
 Fibroid load (cm3) 350 ± 307
 Volume dominant fibroid (cm3) 305 ± 292
 Number of fibroids  
 1 50 (38.5)
 2 or 3 39 (30.0)
 >3 41 (31.5)
 Fibroid location  
 Submucosal intramural 14 (10.8)
 Intramural 86 (66.2)
 Subserosal 22 (16.9)
 Transmurala 8 (6.2)
 T2 signal intensity dark, minimal heterogeneity 71 (54.6)
 Minimal heterogeneity  
 Minimal heterogeneity 71 (54.6)
 Substantial heterogeneity 44 (33.8)
 Isointense 6 (4.6)
 Bright 9 (6.9)